🚀
Enjoy a 7-Day Free Trial Thru Nov 18, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Strategies Created by Users
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Canadian Insider
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
Instant Alerts
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruAI
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
All Topics
General Discussions
Investment Ideas
Strategies
Article Comments
Books
Feedback
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
Sarepta Therapeutics Inc (NAS:SRPT)
Transcripts
Sarepta Therapeutics Inc (NAS:SRPT)
$ 121.61
1.19 (0.99%)
Market Cap: 11.62 Bil
Enterprise Value: 11.82 Bil
PE Ratio: 78.97
PB Ratio: 9.51
GF Score: 86/100
0
Summary
30-Y Financials
Forecast
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Sarepta Therapeutics Inc (SRPT) Transcripts
Q3 2024 Sarepta Therapeutics Inc Earnings Call Transcript
5 days ago
$127.97
(+2.37%)
Earnings
Show Key Points
Q2 2024 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 07, 2024
$140.06
(-1.95%)
Earnings
Show Key Points
Q1 2024 Sarepta Therapeutics Inc Earnings Call Transcript
May 01, 2024
$130.9
(+3.35%)
Earnings
Show Key Points
Q4 2023 Sarepta Therapeutics Inc Earnings Call Transcript
Feb 28, 2024
$137.5
(-2.85%)
Earnings
Sarepta Therapeutics Inc To Provide Program Update Transcript
Jan 29, 2024
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Sarepta Therapeutics Inc at UBS BioPharma Conference Transcript
Nov 09, 2023
Q3 2023 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 01, 2023
$76.52
(+13.68%)
Earnings
Sarepta Therapeutics Inc Update Call Transcript
Oct 30, 2023
Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Q2 2023 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 02, 2023
$105.19
(-2.18%)
Earnings
Sarepta Therapeutics Inc at TD Cowen RNA Therapeutics Summit (Virtual) Transcript
Jul 10, 2023
Sarepta Therapeutics Inc ELEVIDYS FDA Accelerated Approval Call Transcript
Jun 22, 2023
Q1 2023 Sarepta Therapeutics Inc Earnings Call Transcript
May 02, 2023
$123.69
(-1.14%)
Earnings
Sarepta Therapeutics Inc SRP-9001 BLA Update Call Transcript
Mar 16, 2023
Q4 2022 Sarepta Therapeutics Inc Earnings Call Transcript
Feb 28, 2023
$122.13
(+3.39%)
Earnings
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Sarepta Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 01, 2022
Q3 2022 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 02, 2022
$113.42
(-0.58%)
Earnings
Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2022
Q2 2022 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 02, 2022
$94.01
(+2.69%)
Earnings
Sarepta Therapeutics Inc to Discuss New Clinical Data and Integrated Analysis Call Transcript
Jul 06, 2022
Sarepta Therapeutics Inc to Provides Update on SRP-5051 for the Treatment of Duchenne Transcript
Jun 23, 2022
Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 14, 2022
Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 02, 2022
Sarepta Therapeutics Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
Q1 2022 Sarepta Therapeutics Inc Earnings Call Transcript
May 04, 2022
$72.75
(-0.79%)
Earnings
Sarepta Therapeutics Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) Transcript
Mar 31, 2022
Sarepta Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 15, 2022
Sarepta Therapeutics Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 09, 2022
Q4 2021 Sarepta Therapeutics Inc Earnings Call Transcript
Mar 01, 2022
$76.02
(-0.77%)
Earnings
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) and Q&A Session Transcript
Jan 10, 2022
Sarepta Therapeutics Inc at Evercore ISI HealthCONx Virtual Conference Transcript
Nov 30, 2021
Sarepta Therapeutics Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) Transcript
Nov 15, 2021
Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2021
Q3 2021 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 03, 2021
$86.53
(+6.13%)
Earnings
Sarepta Therapeutics Inc to host SRP-9001 Micro-dystrophin R&D Day Transcript
Oct 11, 2021
Sarepta Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 27, 2021
Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021
Q2 2021 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 04, 2021
$67.5
(-2.23%)
Earnings
Sarepta Therapeutics Inc at Bank of America NAPA Healthcare Conference Transcript
Jun 16, 2021
Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021
Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 03, 2021
Sarepta Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 18, 2021
Sarepta Therapeutics Inc Clinical Update: Study SRP-9001-103: 12-Week Expression and Safety Data Using Commercially Representative Material - Call Transcript
May 18, 2021
Sarepta Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021
Q1 2021 Sarepta Therapeutics Inc Earnings Call Transcript
May 05, 2021
$72.77
(-1.69%)
Earnings
Sarepta Therapeutics Inc to Discuss Results from 30 mg/kg Cohort of MOMENTUM Study of SRP-5051 for Duchenne Muscular Dystrophy Call Transcript
May 03, 2021
Pfizer Inc, Avidity Biosciences, Sarepta Therapeutics, Solid Biosciences, and Ultragenyx Pharmaceutical at Guggenheim Partners Healthcare Talks: Genomic Medicines & Rare Disease (Virtual) Transcript
Apr 01, 2021
Sarepta Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 10, 2021
Sarepta Therapeutics Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 03, 2021
Q4 2020 Sarepta Therapeutics Inc Earnings Call Transcript
Mar 01, 2021
$87.03
(-0.03%)
Earnings
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
Sarepta Therapeutics Inc Announces Top-line Results from Part 1 of Study SRP-9001-102 Conference Call Transcript
Jan 07, 2021
Sarepta Therapeutics Inc to Present Clinical Update for SRP-5051 Conference Call Transcript
Dec 07, 2020
Sarepta Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 02, 2020
Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2020
Q3 2020 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 05, 2020
$145.15
(-4.44%)
Earnings
Sarepta Therapeutics Inc Conference Call to Discuss Long-term Functional Data from Gene Therapy Programs to be Presented at WMS25 Transcript
Sep 28, 2020
Sarepta Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2020
Sarepta Therapeutics Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 10, 2020
Q2 2020 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 05, 2020
$158.89
(+1.38%)
Earnings
Sarepta Therapeutics Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript
Jun 24, 2020
Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2020
Sarepta Therapeutics Inc Clinical Update: SRP-9003 for Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript
Jun 08, 2020
Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 04, 2020
Sarepta Therapeutics Inc at RBC Global Healthcare Conference (Virtual) Transcript
May 19, 2020
Q1 2020 Sarepta Therapeutics Inc Earnings Call Transcript
May 06, 2020
$122.57
(+2.62%)
Earnings
Q4 2019 Sarepta Therapeutics Inc Earnings Call Transcript
Feb 26, 2020
$113.63
(-0.14%)
Earnings
Sarepta Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 13, 2020
Sarepta Therapeutics Inc to Discuss Partnership with Roche Holding AG for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy Call Transcript
Dec 23, 2019
Sarepta Therapeutics Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 12, 2019
Q3 2019 Sarepta Therapeutics Inc Earnings Call Transcript
Nov 07, 2019
$93.38
(+1.16%)
Earnings
Sarepta Therapeutics Inc Limb-Girdle Muscular Dystrophy Type 2E Conference Call Transcript
Oct 04, 2019
Sarepta Therapeutics Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Q2 2019 Sarepta Therapeutics Inc Earnings Call Transcript
Aug 07, 2019
$142.26
(-0.87%)
Earnings
Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019
Q1 2019 Sarepta Therapeutics Inc Earnings Call Transcript
May 08, 2019
$114.5
(-1.46%)
Earnings
Sarepta Therapeutics Inc Update on Duchenne Muscular Dystrophy Gene Therapy Program Conference Call Transcript
Mar 25, 2019
Q4 2018 Sarepta Therapeutics Inc Earnings Call Transcript
Feb 27, 2019
$151.68
(+8.31%)
Earnings
Sarepta Therapeutics Inc to Announce Results of Phase I/IIa Gene Transfer Clinical Trial using MYO-101 - Conference Call Transcript
Feb 27, 2019
1